Skip to main content

Table 2 CPS and TPS within elderly HNSCC patients receiving definitive (chemo)radiotherapy

From: Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy

TPS (%)

n

%

0

26

41.3

1–24

27

42.9

25–49

4

6.3

 ≥ 50

6

9.5

CPS

0

21

33.3

1–19

28

44.4

20–49

6

9.5

 ≥ 50

8

12.7